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Background: Fibromyalgia is characterized by widespread musculoskeletal pain 
and often accompanied by cognitive and emotional problems. Adaptation to fibro-
myalgia may therefore also rely on one's ability to regulate emotional problems. In 
this study, we examined two indices of emotion regulation, that is, (a) affective in-
stability, involving frequent large fluctuations in self-reported affect, and (b) resting 
heart rate variability (HRV).
Methods: Participants were 46 patients with fibromyalgia (Mage = 45.4 years; 39 
females) and 46 matched healthy controls (Mage = 44.9 years; 37 females). Heart rate 
was monitored under resting conditions to derive HRV. Subsequently, participants 
completed an electronic end-of-day diary for 14 consecutive days assessing daily 
levels of pain, disability, negative affect (NA) and positive affect (PA). Affective 
instability was operationalized as the mean square of successive differences in daily 
mood.
Results: Results indicate increased levels of NA instability and reduced levels of 
HRV in patients with fibromyalgia in comparison with healthy controls. Furthermore, 
HRV and NA instability were inversely related. Finally, in patients, higher NA insta-
bility was related to increased pain disability.
Conclusions: Current findings support the idea that patients with fibromyalgia are 
confronted with fluctuating emotions. These results may have important implications 
for treatment as they provide support for the use of emotion regulation skills training 
in patients with fibromyalgia to impact upon NA instability.
Significance: This study provides novel insight in the link between emotion regula-
tion indices,that is, heart-rate variability and negative affective (NA) instability, in 
patients with fibromyalgia, and presents evidence for differences in both emotion reg-
ulation indices between patients with fibromyalgia and healthy people. Furthermore, 
results link increased NA instability with increased levels of daily disability in pa-
tients with fibromyalgia. Together, these findings offer support for a key role of emo-
tion regulation in fibromyalgia outcomes, providing pathways for clinical practice.
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1 |  INTRODUCTION
Chronic pain patients often experience a myriad of physi-
cal, cognitive and emotional problems, challenging daily life 
tasks (Taylor et al., 2016). Successful adaptation to chronic 
pain therefore requires the ability to self-regulate, or exert 
control over one's bodily symptoms, thoughts, emotions and 
behaviour (Solberg Nes et al., 2010). Particularly, the regula-
tion of emotions has been argued to be key in the adjustment 
to chronic pain (Hamilton et al., 2005). Indeed, unsuccessful 
regulation of high levels of negative affect, often experienced 
as a consequence of pain, particularly when pain is intense, 
or its impact (e.g. due to missing days at work or school; 
Vos et al., 2012) may maintain and/or worsen pain or limit 
functioning of pain patients (Koechlin et al., 2018). Based on 
this idea, it has been hypothesized that indicators of impaired 
emotion regulation, such as increased affective instability—
that is, the tendency to experience unusually large and/or 
frequent changes in affect—and decreased levels of resting 
heart rate variability (HRV)—that is, a biomarker of latent 
emotion regulation capacity (Holzman & Bridgett,  2017; 
Tracy et  al.,  2016)—would be associated with worse out-
comes in people suffering chronic pain.
For affective instability, initial findings in the field 
(Rost et al., 2016) indicated that chronic pain patients with 
increased negative affect (NA) instability showed greater 
disability. Furthermore, NA instability also moderated the 
association between daily pain and daily disability ratings, 
indicating a stronger association between pain severity and 
disability for patients who are more unstable in their NA. 
Recently, Gerhart et  al.  (2018) corroborated these findings 
by indicating that chronic low back pain patients displaying 
greater NA variability reported higher average levels of pain 
and pain interference than their less emotionally variable 
peers.
For HRV, previous research indicated that chronic pain 
patients have decreased HRV levels compared to healthy 
people (Koenig et  al.,  2016). Yet research has not investi-
gated the role of decreased HRV upon poor health outcomes, 
such as increased disability levels, in chronic pain patients. 
This is surprising as the model of neurovisceral integration 
(Thayer & Lane, 2009) considers HRV as a proxy for prefron-
tal cortical inhibitory capacity and thus supports behavioural 
flexibility and adaptive emotion regulation (Appelhans & 
Luecken, 2006).
Additionally, the link between HRV and daily affec-
tive instability is limited to non-clinical samples (Koval 
et al., 2013). Although these findings suggest that HRV and 
affective instability may be complementary indices of emo-
tion regulation, replicating these findings in clinical samples 
is warranted.
In current study, we investigated whether patients with fi-
bromyalgia differ from matched healthy participants in terms 
of HRV and day-to-day fluctuations in affect. Combining 
a dynamic measure of daily affective experience and the 
self-regulatory biomarker of HRV enables us to expand cur-
rent knowledge about the role of emotion regulation in fi-
bromyalgia, as well as to explore further links between HRV 
and affective instability. In particular, we hypothesize that 
patients with fibromyalgia show higher levels of NA insta-
bility, and lower levels of HRV than healthy controls (H1). 
We furthermore hypothesize that NA instability is negatively 
associated with HRV in both groups (H2). Additionally, and 
replicating our previous findings (Rost et al., 2016), we hy-
pothesize that NA instability is related to daily disability 
(H3a) and moderates the relationship between daily pain 
severity and disability in patients with fibromyalgia (H3b). 
For each of the hypotheses, we also explored the role of PA 
instead of NA instability.
2 |  MATERIALS AND METHODS
2.1 | Participants
Participants between the ages of 18 and 65  years were re-
cruited as part of a large research project (see ASEF-I pro-
tocol; http://hdl.handle.net/1854/LU-5686902). Individuals 
were eligible for participation if they were diagnosed with 
fibromyalgia (assessed at a multidisciplinary pain clinic) and 
fulfilled the 2010 diagnostic criteria for fibromyalgia (fi-
bromyalgia group), or if they did not report a current pain 
problem (control group). Furthermore, participants were ex-
cluded if they (a) had insufficient knowledge of the Dutch 
language; (b) had a neurological condition (e.g. epilepsy); (c) 
were unable to use both index fingers; (d) reported abnormal 
sensations on the arm, or (e) did not have normal or corrected-
to-normal eyesight. The latter three criteria were exclusion 
criteria related to a task that was not part of the present study 
(see http://hdl.handle.net/1854/LU-5686902). Patients with 
fibromyalgia were recruited via a Multidisciplinary Pain 
Clinic. They were informed about the study via a poster ad-
vertisement in the waiting room of the hospital. Patients who 
were interested in taking part in this study, left their contact 
details, and were later contacted to be screened for eligibility. 
Healthy controls were recruited via advertisements in a local 
newspaper, flyers and the university website. Individuals 
who volunteered were contacted and screened for eligibility. 
Both groups were matched for age, sex and educational level. 
A total of 98 individuals took part in the study, that is, 49 
patients with fibromyalgia and 49 healthy controls.
As the study was part of an extended protocol, we only re-
port the procedure relevant for the current research question 
(for all study protocol details, see http://hdl.handle.net/1854/
LU-5686902). Before coming to the laboratory, participants 
completed a questionnaire battery, including the Depression 
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Anxiety Stress Scales (DASS; Lovibond & Lovibond, 
1995), Pain Disability Index (PDI; Pollard,  1984) and 
Multidimensional Pain Inventory (MPI; Kerns et  al.,  1985; 
Lousberg et al., 1999) online via LimeSurvey or (for partic-
ipants who were unable to complete the questionnaires on-
line) with paper and pencil. Upon arrival at the laboratory, 
the experimenter orally assessed the ACR-criteria (Wolfe 
et al., 2010) via the Widespread Pain Index. At the start of 
the laboratory session, participants’ heart rate was mea-
sured for 10  min at rest to derive HRV. At the end of the 
laboratory session, participants received instructions for a 
14-day diary protocol. The study design was approved by the 
Ethics Review Panel of the University of Luxembourg and 
the Medical Ethics Committee from the University Hospital 
Ghent. Participants gave written informed consent and were 
reimbursed 35€ for participation.
2.2 | Questionnaires
Depressive mood, anxiety and stress were assessed using the 
DASS (Lovibond & Lovibond,  1995). Each subscale con-
tains 14 items on which participants rate how much they have 
experienced each state (e.g. ‘I found it hard to wind down’, ‘I 
felt I was pretty worthless’) over the past week using a scale 
ranging from 0 (did not apply to me at all) to 3 (applied to 
me very much, or most of the time). Scores for each subscale 
ranged from 0 to 42. In the present study, internal consisten-
cies were excellent (α = 0.97 for depression, α = 0.91 for 
anxiety, and α = 0.95 for stress).
Pain severity at baseline was assessed with the pain se-
verity subscale of the MPI (Kerns et  al.,  1985; Lousberg 
et  al.,  1999). Part I of the MPI consists of five subscales 
assessing the impact of pain (i.e. pain severity, pain inter-
ference, social support, perceived life control and affective 
distress) on a 7-point Likert scale. Each subscale has a scale 
range from 0 to 6. The used pain severity subscale includes 
two items (i.e. ‘Rate the level of your pain at the present mo-
ment’ and ‘On average, how severe has your pain been during 
the last week’?). A third item (‘How much suffering do you 
experience because of your pain’?) was not used as its content 
relates to suffering rather than pain severity (see Parenteau & 
Haythornthwaite,  2011; Van Ryckeghem et  al.,  2013). The 
MPI has shown good reliability and validity (Rudy, 1989). In 
the present study, Cronbach's alpha of the MPI pain severity 
subscale was 0.84.
Pain-related disability at baseline was measured with the 
PDI (Pollard,  1984). In particular, participants indicate the 
degree of disability experienced in seven life domains (e.g. 
family and occupation) using a scale from 0 (no disability) 
to 10 (total disability). Participants are asked to respond to 
each category by indicating the overall impact of pain in their 
life, not just when pain is at its worst. Questionnaire scores 
range between 0 and 70. In current study, Cronbach's alpha 
was 0.82.
2.3 | HRV
To assess HRV under resting conditions, participants were 
seated in individual cubicles and were instructed to sit quietly 
and relax while their heart rate was monitored. Heart rate was 
assessed with electrocardiographic recordings for 10 min at 
a sampling rate of 1,000 Hz using a Polar watch RS800CX 
(Polar Electro Oy). HRV was derived from the last 5 min of 
the recording.
2.4 | End-of-day diary assessment
Participants completed an online diary at the end of each 
day for two consecutive weeks. They were reminded to do 
so each evening around 7 p.m. via a text message. The diary 
took approximately 5  min to complete. Here we describe 
only the items relevant for the current analyses. Items were 
developed iteratively by a group of pain researchers and pi-
loted for feasibility in patients with chronic pain.
2.4.1 | Daily affect
To assess participants’ daily experience of several af-
fective states, participants answered 16 statements (e.g. 
‘Today, I felt enthusiastic’; 0  =  do not agree at all and 
6  =  totally agree; see also Russell & Carroll,  1999). 
Particularly, we used six adjectives to measure PA: glad, 
enthusiastic, happy, relaxed, strong and proud; and 10 ad-
jectives to measure NA: afraid, irritated, angry, powerless, 
sad, frustrated, dejected, infuriated, hopeless and nervous1. 
Items were derived from a validation study investigating 
the representation of emotion terms in a general popula-
tion and a previous study investigating affective instabil-
ity in chronic pain patients (Rost et al., 2016; Veirman & 
Fontaine,  2015). PA and NA scales were calculated by 
averaging PA and NA items respectively. We calculated 
within-person reliability of the PA and NA scales using the 
Generalizability theory approach described by Bolger and 
Laurenceau (2013). Estimates of within-person reliability 
were 0.86 for PA and 0.86 for NA.
2.4.2 | Daily pain severity
Daily pain severity was assessed using the item: ‘On average, 
how severe has your pain been today’? rated on a scale from 
0 (no pain) to 10 (worst imaginable pain).
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2.4.3 | Daily pain disability
Daily pain disability was assessed by the item ‘To what ex-
tent did pain interfere with your planned activities today’? 
rated on a scale from 0 (not at all) to 10 (very much). This 
item is similar to the items in the PDI, but it asks more gener-
ally about the degree to which pain prevents patients from 
their planned daily activities.
2.5 | Affective instability
Affective instability refers to the experience of frequent 
and large successive changes in feelings over time (Jahng 
et  al.,  2008), and is typically measured using the square 
of successive differences (SSD; Jahng et al., 2008) which 
reflects the magnitude of change in consecutively assessed 
affective states and it is therefore a function of both vari-
ability (i.e. average magnitude of affective changes) and 
temporal dependency (i.e. average frequency of affec-
tive changes; Jahng et al., 2008; see further for statistical 
information).
2.6 | Data handling and reduction
To calculate HRV-indices, sequential interbeat intervals 
were downloaded using the software Polar Pro Trainer 
5. All signals were visually inspected for artefacts. HRV 
analysis was performed using ARTiiFACT (Kaufmann 
et  al.,  2011). First, measurement artefacts were identi-
fied by applying a distribution-related threshold criterion. 
Erroneous beats were deleted and substituted by cubic 
spline interpolation of neighbouring intervals. Time domain 
measures were directly calculated from RR-interval series. 
Spectral analysis of the RR-interval series was carried out 
using Fast Fourier Transformation. Following the recom-
mendations of the Task Force of the European Society of 
Cardiology and the North American Society of Pacing and 
Electrophysiology (1996), we defined the high frequency 
band (HF) as 0.14 to 0.4 Hz and used the following time 
and frequency HRV parameters for statistical analyses: 
root mean square of successive differences (RMSSD) and 
the absolute power in the HF band (HFabs; Task Force of 
the European Society of Cardiology & the North American 
Society of Pacing & Electrophysiology,  1996). We fo-
cused on those parameters because they closely reflect 
parasympathetic control over heart rate (Task Force of the 
European Society of Cardiology & the North American 
Society of Pacing & Electrophysiology,  1996), which is 
considered directly relevant to an individual's capacity to 
regulate emotions (Appelhans & Luecken,  2006; Thayer 
& Lane,  2000, 2009). The criterion for outliers in HRV 
measures was defined as values more than 3 SD above the 
sample mean (cf. Koval et al., 2013). After correcting for 
outliers, HFabs was log transformed to adjust for skewness 
of the distribution (lnHFabs).
To model affective instability, following Jahng 
et al. (2008), we conducted analyses using squared successive 
differences (SSDs), which were calculated by subtracting 
each participant's reported affect level on a given day from 
their affect level reported on the following day for each of 
the 14 days. This resulted in a time series of up to 13 succes-
sive (day-to-day) differences for each participant, which were 
squared to obtain SSDs. SSDs were calculated separately 
for PA and NA ratings. SSDs were log transformed to ad-
just for skewness of the distribution. Skewness values for the 
SSD before log-transformation were 4.6 (PA) and 4.1 (NA), 
which decreased to −0.78 (PA) and −0.46 (NA) after log 
transformation. In addition, the MSSD index was calculated 
for NA and PA, reflecting the average frequency and size of 
day-to-day fluctuations in affect over 14 days (see Houben 
et al., 2015; Rost et al., 2016).
One control participant was excluded from the final analy-
ses due to equipment failure. A further two participants (1 pa-
tient, 1 control) were excluded because they were outliers on 
HRV. To ensure that affective instability could be modelled 
reliably, three additional participants (2 patients, 1 control) 
who completed fewer than 7 out of 14 days of diary entries 
were excluded from analyses. The final sample consisted of 
46 patients with fibromyalgia and 46 healthy controls. For 
these participants, 93.79% of requested dairy entries were 
filled out.
2.7 | Statistical models
Descriptive statistics were calculated using SPSS 24.0 for 
Windows (SPSS Inc.). For our main analyses we ran mul-
tilevel regressions using HLM (Version 7.01; Scientific 
Software International) to account for the nested structure of 
the data (daily diary reports nested within individuals) and 
handle missing data at level 1. All multilevel models included 
random intercepts and slopes and were estimated using full 
maximum likelihood.
2.7.1 | Model 1: Affective instability as a 
function of HRV in patients with fibromyalgia and 
healthy controls
Model 1 was built to test group differences in affective in-
stability and HRV (H1), and negative association between 
affective instability and HRV in both groups (H2). We 
modelled the (log transformed) within-person SSD (lnS-
SDaffectij) using a multilevel random intercept model, in 
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which the Level 1 random intercept (β0j) was predicted by 
vagally mediated HRV and group (dummy coded 0 = con-
trol; 1 =  fibromyalgia) at Level 2. We controlled for the 
mean of daily PA or NA ratings (at Level 2) to ensure that 
findings were not driven by differences in prevailing affect 
levels (Ebner-Priemer et  al.,  2009; Russell et  al.,  2007). 
Vagally mediated HRV and mean affect were standardized 
to facilitate interpretation (Nezlek, 2012), and group was 
entered uncentred. PA and NA instability were modelled 
in separate analyses and the equations, including the sub-
scripts i representing days and j representing persons, were 
as follows:
2.7.2 | Model 2: The relationship between 
affective instability and daily disability in patients 
with fibromyalgia
Model 2 was built to test the positive association between 
affective instability and daily disability (H3a) and the mod-
erating effect of affective instability on the relationship be-
tween daily pain severity and disability in patients (H3b). 
We modelled daily disability using a multilevel random 
intercept and slope model. We ran analyses exclusively in 
patients with fibromyalgia as the variance of the diary data 
of healthy control subjects was limited, that is, ratings were 
≤2 on scales from 0 to 10 in 85% for daily pain severity 
and 90% for daily disability. We followed a model building 
procedure in our analyses (Raudenbush & Bryk, 2002). To 
maximize stability and reliability of the findings, we ex-
cluded control variables from further steps in model build-
ing if their effects proved to be non-significant (Kreft & 
de Leeuw, 1998). Level 1 variables consisted of the daily 
diary measures of pain intensity and pain disability. All 
level 1 variables were continuous and entered person-mean 
centred (Enders & Tofighi, 2007). At level 2, in addition 
to the main predictors mean levels of daily affect and af-
fective instability, we also included gender, age, baseline 
disability, baseline pain intensity and pain duration as 
control variables. Gender was dummy coded (0 = female; 
1 = male) and entered uncentred, whereas all continuous 
Level 2 variables were standardized to facilitate interpreta-
tion (Nezlek, 2012). We controlled for mean level of daily 
affect when investigating the moderating role of affective 
instability in the final models:
3 |  RESULTS
3.1 | Participant characteristics and group 
differences
Table 1 shows sample demographics and descriptive statistics 
for all measures. There were no significant group differences 
in age, sex or educational level (all ps > .441). For patients 
with fibromyalgia, the mean pain duration was 189.9 months 
(SD = 117.8). Mean pain severity was 3.62 as measured by 
the MPI (SD = 1.10) and mean disability was 41.9 on the PDI 
(SD = 10.5). These mean levels are comparable with previ-
ous studies of chronic pain patients (MMPI = 4.2, SDMPI = 1.1, 
MPDI = 44.6, SDPDI = 13.4; Chibnall & Tait, 1994; Nicholas 
et  al.,  2008). Furthermore, patients with fibromyalgia had 
significantly higher scores on depression [t(72) = 3.98], anxi-
ety [t(64) = 6.77], and stress [t(90) = 4.53] than healthy con-
trols (all ps < .001).
Furthermore, relative to the control group, patients 
with fibromyalgia showed lower mean levels of daily PA 
(t(90) = 1.28, p <  .001), but did not differ significantly in 
their mean levels of NA (p = .204). Table 1 gives an overview 
of all measures.
3.2 | Multilevel analyses
3.2.1 | Affect instability as a function of HRV 
in patients with fibromyalgia and healthy controls
Model 1 tested H1 and H2, that is, patients show higher 
levels of affect instability and lower levels of HRV and a 
negative association between affect instability and HRV in 
both groups. We examined how Group (fibromyalgia vs. 
control) and each index of HRV were related to NA insta-
bility, while controlling for the mean level of NA (Model 
1a and 1b; see also Figure  1). As predicted, Group was 
positively associated with NA instability, indicating that 
patients with fibromyalgia showed significantly higher 
levels of NA instability. Furthermore, results indicated 
that NA instability was negatively associated with HRV-
RMSSD, linking lower vagally mediated HRV to higher 
NA instability (see Model 1a in Table 2). Results investi-
gating the link between NA instability and lnHFabs pointed 
in the same direction but failed to reach statistical signifi-
cance (see Model 1b in Table 2). Results for PA instability 
showed that PA instability was not related to Group and 
HRV-indices, while controlling for the mean level of PA 
(See Models 1c and 1d in Table 2).
H1 is further supported by significant group differ-
ences (t-tests) reporting higher levels of NA instability 
(p < .01) but not of PA instability (p = .16) in patients with 
fibromyalgia compared to healthy controls (see Table 1). 
Level 1: ln(SSDaffectij ) = 0j + rij
Level2: 0j = γ00 + γ01 ∗ groupj + γ02 ∗ HRVj
+γ03 ∗ meanaffectj + μ0j,
Level 1: daily disability = 0j + 1j ∗ daily pain severityij + rij
Level 2 0j = γ00 + γ01 ∗ mean daily affectj + γ02 ∗ affect instabilityj + μ0j
1j = γ10 + γ11 ∗ mean daily affectj + γ12 ∗ affect instabilityj + μ1j
.
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Moreover, t-tests comparing groups on HRV supports H1 
with regard to group differences in HRV, more precisely 
lower HRV in patients with fibromyalgia than in healthy 
subjects (Table 1). Both these results support group dif-
ferences of NA instability and HRV as hypothesized in 
H1.
3.3 | Daily disability and affective instability 
in patients with fibromyalgia
Model 2 tested H3a and H3b, that is, that affective instability 
is related to daily disability and moderates the relationship 
between daily pain severity and disability. This model was 
tested in the patients’ sample only (see also section ‘statisti-
cal models’).
NA instability
Based on the model building procedure, we found Age to 
be a significant predictor for the intercept of Daily disability 
(B = 0.48, t(38) = 2.57, p =  .01), indicating that older pa-
tients reported higher levels of daily disability. Therefore, we 
included Age as a Level 2 predictor in the final model. Final 
analyses indicated several Level 2 variables as significantly 
predicting the Level 1 intercept: Age (B = 0.49, t(42) = 2.20, 
p =  .03), Mean level of daily NA (B = 0.53, t(42) = 2.09, 
p = .04) and NA instability (B = 0.41, t(42) = 2.03, p < .05). 
These findings indicate that daily disability increased with 
age, higher mean levels of daily NA and higher levels of NA 
instability, thus supporting H3a. The slope (i.e. moderat-
ing effect of NA instability) was found to be not significant 








Age (M, SD) 45.4 (9.2) 44.9 (12.2) t(84)a = 0.14, 
p = .885, d = 0.05
Sex (n women) 39 37 χ2(1) = 0.303, 
p = .582, w = 0.06
Educational level χ2(2) = 1.64, p = .441, 
w = 0.13
College/University 41.3% 54.3%
Secondary school 54.3% 41.3%
Primary school 4.3% 4.3%
DASS-depression (M, SD) 13.0 (10.9) 5.6 (6.4) t(72)a = 3.98, 
p < .001, d = 0.83
DASS-anxiety (M, SD) 11.1 (7.5) 2.8 (3.6) t(64)a = 6.77, 
p < .001, d = 1.39
DASS-stress (M, SD) 15.0 (7.6) 7.9 (7.4) t(90) = 4.53, p < .001, 
d = 0.95
Mean daily PA (M, SD) 2.6 (1.0) 3.4 (1.0) t(90) = 3.75, p < .001, 
d = 0.81
Mean daily NA (M, SD) 1.4 (0.7) 1.2 (0.9) t(90) = 1.28, p = .204, 
d = 0.29
Ln NA instability (M, SD) −1.6 (1.1) −2.5 (1.5) t(90) = 3.29, p = .002, 
d = 0.69
Ln PA instability (M, SD) −1.3 (1.1) −1.7 (1.1) t(90) = 1.43, p = .157, 
d = 0.30
HRV-indices
RMSSD (M, SD) 19.1 (10.9) 26.4 (14.0) t(90) = 2.77, p = .007, 
d = 0.58
lnHFabs (M, SD) 4.7 (1.3) 5.2 (1.2) t(90) = 1.92, p = .058, 
d = 0.40
Abbreviations: DASS, Depression, Anxiety and Stress Scales; HRV, heart rate variability; lnHFabs, log 
transformed absolute power in the HF band; NA, negative affect; PA, positive affect; RMSSD, root mean 
square of successive differences.
T A B L E  1  Descriptive statistics by 
participant group
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3.4 | PA instability
Analyses of the model building procedure revealed that 
Age (B = 0.42, t(38) = 2.15, p =  .038) and Baseline pain 
severity (B = 0.58, t(38) = 2.01, p = .052) were predictors 
for the intercept, indicating that older patients and patients 
reporting greater Baseline pain severity reported more dis-
ability in daily life. Both predictors were, therefore, in-
cluded in the final model. Final analyses showed that Age 
(B = 0.44, t(41) = 2.23, p = .031) and Baseline pain severity 
(B = 0.68, t(41) = 3.27, p < .01) remained significant predic-
tors for Daily disability. Also, Daily pain severity (B = 0.88, 
t(43) = 13.24, p < .001) was a significant predictor of Daily 
disability in the final Model. Of particular interest, PA in-
stability was not related to daily disability. Also, the slope 
(i.e. moderating effect of PA instability) was not significant 
(B = 0.03, t(43) = 0.63, p = .53). Results of the final models 
predicting daily disability are presented in Table 3.
4 |  DISCUSSION
Within the current study, we investigated group differences 
between patients with fibromyalgia and healthy controls in 
terms of affective instability and resting HRV (two indices of 
emotion regulation capacity). Additionally, the relationship 
between HRV and affective instability across both groups 
was examined as well as the relationship between affective 
instability and daily disability in patients with fibromyalgia. 
Results of our study can be readily summarized. First, pa-
tients with fibromyalgia showed higher levels of NA insta-
bility and lower levels of resting HRV than healthy controls. 
Second, HRV (RMSSD) was negatively associated with NA 
instability, although not with PA instability. Third, NA in-
stability predicted daily disability. However, in contrast with 
previous findings (Rost et al., 2016), affective instability did 
not moderate the association between daily pain severity 
and pain disability. Each of these findings deserves further 
exploration.
Within the current study, we observed higher levels of NA 
instability in patients with fibromyalgia compared to healthy 
people. This is in line with previous research indicating that 
chronic low back pain patients display greater NA variabil-
ity than their spouses do (Gerhart et  al.,  2018) and similar 
research comparing levels of NA instability between healthy 
people and people suffering from other psychological disor-
ders (e.g. Thompson et al., 2012). These findings indicate that 
experiencing chronic pain is related to increased NA instabil-
ity. This was observed even when controlling for mean neg-
ative emotion levels, showing that NA instability has unique 
features compared to mean negative emotion levels. These 
findings may be explained by the fact that chronic pain pres-
ents constant challenges to a person, needing adequate coping 
strategies. Due to these constant challenges, it is likely that in 
some instances, flexible adaptation of coping strategies to the 
F I G U R E  1  Standardized NA instability scores per Group 
(healthy controls; fibromyalgia [FM] patients per Standardized HRV-
RMSSD score (low [25th percentile]; high [75th percentile])
T A B L E  2  Results of multilevel models predicting instability of 
positive and negative affect from group and HRV-indices
Predictor B SE P
Model 1 for NA instability
Model 1a Intercept (γ00) −2.32 0.20 <.001
Group (γ01) 0.62 0.26 .021






Model 1b Intercept (γ00) −2.37 0.20 <.001
Group (γ01) 0.71 0.25 .006






Model 1 for PA instability
Model 1c Intercept (γ00) −1.49 0.40 <.001
Group (γ01) −0.02 0.25 .946






Model 1d Intercept (γ00) −1.54 0.16 <.001
Group (γ01) 0.05 0.24 .826






Abbreviations: HRV, heart rate variability; lnHFabs, log transformed absolute 
power in the HF band; NA, negative affect; PA, positive affect; RMSSD, root 
mean square of successive differences.
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context fails or that after continuous challenges to cope with 
chronic pain and/or related problems, people fail to remain 
coping with these challenges, resulting in a wide variability 
in negative emotions (Solberg Nes et al., 2009). Besides, dif-
ferences in variability in negative emotions between healthy 
people and patients with fibromyalgia, current findings also 
indicate that both, higher mean levels of negative affect and 
higher variability in negative emotions, were related to higher 
daily disability. Current findings replicate our previous find-
ing that mean daily NA and NA instability are significantly 
related to daily disability in a different, that is, homogenous 
fibromyalgia, patient sample, suggesting that patients report-
ing more NA and NA instability experience more disability in 
daily life (Rost et al., 2016). Furthermore, this is in line with 
recent findings of Gerhart et al. (2018) indicating that mo-
ment-to-moment variability of NA is related to daily disabil-
ity in chronic low back pain patients. These findings provide 
further support for the suggestion of Hamilton et al. (2005) 
who proposed that individual differences related to emotional 
processing and specifically emotion regulation might be an 
important factor in the adaptation to chronic pain. Koechlin 
et al. (2018) suggest that this link may be due to the fact that 
unsuccessful regulation of high levels of negative affect main-
tains/worsens pain or limits functioning of pain patients. This 
may on its turn fuel one's level of affective instability again, 
and as such become a vicious reinforcing circle. Yet, it may 
also be that persistent pain and emotion dysregulation share 
similar underlying mechanisms (Linton, 2013). For example, 
negative repetitive thinking, might operate as a transdiagnos-
tic factor, that is, serve as a driver for emotional and pain-re-
lated problems (Flink et  al.,  2013; Linton, 2013). Negative 
repetitive thinking might function in order to downregulate 
NA in stressful situations such as experiencing persistent 
pain or emotional distress (Flink et al., 2013). When this form 
of repetitive thinking occurs in other contexts and spins out 
of control, however, it becomes a form of ineffective problem 
solving that drives the development of emotional and phys-
ical problems (Eccleston & Crombez, 2007; Linton, 2013).
The assumption that affective instability reflects dysregu-
lated emotion is further corroborated by the finding that HRV 
and NA instability are associated with each other. HRV is driven 
by a flexible network of neural structures, which is dynamically 
organized and allows for behavioural adaptability, thus, indexing 
regulated emotional responding (Appelhans & Luecken, 2006). 
The link between vagally mediated HRV has previously been 
reported as predicting lower levels of emotional instability by 
Koval et al. (2013) in a healthy sample. Yet, the current study 
is the first to show a relationship between emotional instabil-
ity, in particular NA instability, and vagally mediated HRV in 
a chronic pain population. This link was, however, specific for 
NA instability, and not for PA instability. This finding is not un-
expected and may relate to a lower PA/NA balance in patients 
with fibromyalgia than in healthy individuals. It could be argued 
that in patients with fibromyalgia, HRV is mainly associated 
with the downregulation of NA.
Next, it should be noted that we could not completely 
replicate our previous findings (Rost et  al.,  2016), show-
ing that NA instability is related to daily disability, and 
moderates the relationship between daily pain severity and 
disability in patients with fibromyalgia (H3b). Indeed, al-
though we found again evidence for a relationship between 
NA instability and daily disability, we were unable to find 
support for the moderating effect of NA instability on the 
relationship between daily pain severity and disability in 
patients with fibromyalgia. This is in contrast with our 
previous research showing that the association between 
daily pain severity and daily disability as well as cognitive 
complaints is stronger in patients who report higher NA 
instability compared to patients experiencing lower day-to-
day fluctuations of NA (Rost et al., 2016). One explanation 
for the divergence of the current findings from our previ-
ous results might relate to insufficient power of the multi-
level moderation analysis. The average Level 1 and Level 
T A B L E  3  Final hierarchical linear models iwith regard to daily 
disability in fibromyalgia patients
Model 2 for daily 
disability B SE p
Final model for NA
Intercept (γ00) 4.75 0.23 <.001
Mean daily NA (γ01) 0.53 0.25 .043
NA instability (γ02) 0.41 0.20 .048
Age (γ03) 0.49 0.22 .033









Final model for PA
Intercept (γ00) 4.78 0.17 <.001
Mean daily PA (γ01) −0.25 0.25 .338
PA instability (γ02) 0.01 0.15 .941
Age (γ03) 0.44 0.20 .031
Baseline pain severity 
(γ04)
0.68 0.21 .002









Abbreviations: NA, negative affect; PA, positive affect.
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2 sample sizes are of major importance in determining the 
detection of cross-level interactions (Mathieu et al., 2012) 
and may have been too small to allow for the detection of 
cross-level interactions.
Finally, it is worth noting that the current study clearly 
found differential findings for PA instability and NA instabil-
ity. This is not surprising as a wealth of research has indicated 
that PA is relatively independent from NA (e.g. Watson & 
Clark, 1992). These differential findings were also found in 
previous research in psychopathology investigating affective 
instability in natural contexts (Houben et al., 2015; Thompson 
et al., 2012; Trull et al., 2008). For example, depressed pa-
tients show higher NA instability, but not PA instability, 
compared with healthy volunteers. (Thompson et al., 2012). 
Similarly, previous research of our group (Rost et al., 2016) 
only found a link between NA instability and poor pain out-
comes. These findings may be explained by the fact that there 
are fewer fluctuations in PA than NA. Inspection of the SDs 
of both NA instability and PA instability offers some support 
for this explanation. Yet, it may also be that our measure of 
NA instability captures a unique aspect of emotion regulation 
which is not captured by our measure of PA instability. Future 
research is warranted on the differential effects between NA 
and PA instability.
Our findings may have clinical implications as they indi-
cate that therapeutic treatment for chronic pain populations 
could aim to provide chronic pain patients with strategies 
to improve regulating negative emotions which are often 
inherent to the presence of chronic pain. For instance, the 
inclusion of specific emotion regulation skills training (e.g. 
Berking & Whitley, 2014) and mindfulness-based approaches 
(Grossman et al., 2007; Rosenzweig et al., 2010) may offer 
promising approaches for the psychological treatment of 
fibromyalgia.
This study has also several considerations. First, we as-
sessed day-to-day fluctuations in affect using end-of-day 
diaries. This is in line with our previous research (Rost 
et al., 2016). Yet, generalization of current findings to with-
in-day emotional fluctuations warrants further research. 
Second, affective instability is a global index that captures 
temporal variability of emotions (in this case over 14 days). 
We cannot draw conclusions, however, regarding the individ-
ual or contextual factors underlying individual differences in 
affective instability in our sample. In addition, the amount 
of emotion terms for PA and NA was imbalanced. Future re-
search may want to balance the number of PA and NA items 
to avoid potential bias in one or the other direction. Third, 
the current study investigated the relationship between HRV, 
emotional instability and disability due to pain. Future re-
search should investigate the link with other psychological 
variables, such as worry or rumination, to become closer to 
identifying possible shared underlying mechanism of both 
emotional and pain-related problems. Fourth, it should be 
noted that HRV is not uniquely linked to emotion regulation 
and as many physiological indicators, it may be influenced 
by effects of the situation and person–situation interaction. 
Although resting HRV assessment was highly standardized 
in the current study, future research may aim to include at 
least two measurements to aggregate in order to diminish the 
potential influence of state variables (Bertsch et al., 2012). 
Fifth, two HRV-indices were included in the current study. 
It should be noted that although pointing in the same direc-
tion, findings with both indices did not mirror each other ex-
actly. This finding is in line with earlier research, whereby 
the RMSSD index of HRV has been preferred because of 
its robust statistical properties (Task Force of the European 
Society of Cardiology & the North American Society of 
Pacing & Electrophysiology,  1996). Sixth, one should be 
cautious to infer causal relationships from our data. Indeed, 
we did not experimentally manipulate variables, so we can-
not exclude that other, hidden and unmeasured variables play 
a role. Furthermore, the shared neurophysiological mecha-
nisms of emotion regulation, pain perception and physiologi-
cal correlates such as cortico-cardiac interaction as expressed 
in HRV, challenge any attempt of disentanglement of causal 
pathways and require future research under controlled exper-
imental conditions. Future research addressing the causal na-
ture between HRV and affecting instability and poor health 
outcomes is therefore warranted.
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